Aware Super Pty Ltd as trustee of Aware Super Purchases Shares of 313,567 DocuSign, Inc. (NASDAQ:DOCU)

Aware Super Pty Ltd as trustee of Aware Super purchased a new stake in DocuSign, Inc. (NASDAQ:DOCU) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 313,567 shares of the company’s stock, valued at approximately $28,202,000. Aware Super Pty Ltd as trustee of Aware Super owned about 0.16% of DocuSign at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. FMR LLC grew its holdings in DocuSign by 178.2% during the 4th quarter. FMR LLC now owns 6,101,024 shares of the company’s stock valued at $548,726,000 after buying an additional 3,908,139 shares during the last quarter. American Century Companies Inc. lifted its position in shares of DocuSign by 18.5% in the fourth quarter. American Century Companies Inc. now owns 5,315,459 shares of the company’s stock valued at $478,072,000 after acquiring an additional 831,611 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of DocuSign by 4.9% in the fourth quarter. Renaissance Technologies LLC now owns 4,363,292 shares of the company’s stock valued at $392,434,000 after acquiring an additional 205,304 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of DocuSign by 7.2% during the fourth quarter. Geode Capital Management LLC now owns 3,732,363 shares of the company’s stock valued at $335,147,000 after acquiring an additional 249,179 shares during the last quarter. Finally, Invesco Ltd. increased its position in DocuSign by 283.9% during the 4th quarter. Invesco Ltd. now owns 3,447,275 shares of the company’s stock worth $310,048,000 after purchasing an additional 2,549,310 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

DocuSign Stock Up 1.5 %

Shares of DOCU stock opened at $74.35 on Monday. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86. The firm’s 50 day moving average price is $82.95 and its two-hundred day moving average price is $82.90. The stock has a market cap of $15.06 billion, a price-to-earnings ratio of 15.33, a price-to-earnings-growth ratio of 6.94 and a beta of 1.20.

DocuSign (NASDAQ:DOCU) last posted its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The business had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. During the same quarter in the previous year, the business posted $0.76 EPS. The business’s quarterly revenue was up 9.0% on a year-over-year basis. On average, equities analysts forecast that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

Insider Activity at DocuSign

In related news, CFO Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock in a transaction on Friday, February 14th. The shares were sold at an average price of $86.90, for a total transaction of $695,200.00. Following the sale, the chief financial officer now owns 77,851 shares of the company’s stock, valued at $6,765,251.90. The trade was a 9.32 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $87.41, for a total transaction of $46,676.94. Following the completion of the transaction, the director now directly owns 8,270 shares of the company’s stock, valued at approximately $722,880.70. The trade was a 6.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 47,851 shares of company stock worth $3,998,719. 1.66% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on DOCU shares. JPMorgan Chase & Co. upgraded shares of DocuSign from an “underweight” rating to a “neutral” rating and upped their target price for the company from $70.00 to $75.00 in a report on Monday, March 10th. Royal Bank of Canada reissued a “sector perform” rating and set a $90.00 price objective on shares of DocuSign in a research note on Friday, March 14th. Jefferies Financial Group lowered their target price on shares of DocuSign from $115.00 to $105.00 and set a “buy” rating for the company in a research note on Monday, March 31st. HSBC upgraded DocuSign from a “reduce” rating to a “hold” rating and set a $70.00 price target for the company in a report on Friday. Finally, UBS Group decreased their price objective on DocuSign from $100.00 to $90.00 and set a “neutral” rating on the stock in a report on Friday, March 14th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $93.85.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.